The mechanism of action of acetylsalicylic acid (ASA), which is part of Cardiomagnyl, is irreversible inhibition of COX-1, which blocks the synthesis of thromboxane A 2 and inhibits platelet aggregation. It is believed that ASA has other mechanisms for suppressing platelet aggregation, which expands its use in various vascular diseases. ASA also has an anti-inflammatory, analgesic, antipyretic effect.
Magnesium hydroxide, which is another part of Cardiomagnyl, protects the mucous membrane of the gastrointestinal tract from the effects of ASA.
- Primary prevention of cardiovascular diseases such as thrombosis and acute heart failure in the presence of risk factors (eg diabetes, hyperlipidemia, hypertension, obesity, smoking, old age);
- Prevention of repeated myocardial infarction and thrombosis of blood vessels;
- Prevention of thromboembolism after surgical interventions on vessels (aortocoronary bypass, percutaneous transluminal coronary angioplasty);
- Unstable angina.
Package: 30 tabs 75 mg +15.2 mg